ASX Announcement 30 October 2026 Quarterly Activities & Cash Flow Report Quarter ended 30 September 2026 OncoSil Medical Achieves Landmark U.S. FDA Approval and Accelerates Global Commercial Expansion in Q1 FY27 Key highlights • Strong revenue growth reflects increasing commercial adoption – Q1...